Agilon Health vs Astrana Health
Agilon Health is the larger business, with $5.93bn of revenue in fiscal 2025 against $3.18bn for Astrana Health (1.9 times as much). Astrana Health grew faster (56.4% against -2.1%). Astrana Health kept more of each dollar of sales as profit: a net margin of 0.7% against -6.6%. Agilon Health carries less debt relative to equity (27.6% against 135.0%).
| Latest fiscal year | Agilon HealthAGL, 2025 | Astrana HealthASTH, 2025 |
|---|---|---|
| Revenue | $5.93bn | $3.18bn |
| Revenue growth | -2.1% | 56.4% |
| Net income | −$391m | $22.5m |
| Operating margin | -7.8% | 2.5% |
| Net margin | -6.6% | 0.7% |
| Return on equity | -131.0% | 3.0% |
| Free cash flow | −$119m | $104m |
| Cash | $174m | $429m |
| Total debt | $35.0m | $1.05bn |
| Debt to equity | 27.6% | 135.0% |
| Dividend per share | — | — |
| Dividend yield | — | 0.1% |
| Share buybacks | $0 | $25.6m |
| Employees | 856 | 3,000 |
| Market value | $1.47bn | $1.78bn |
| Price vs our value range | — | Below our value range |
| Moat score | 12 (Weak) | 36 (Weak) |
| Insider trades, 12 months | 5 buys, 0 sales | 0 buys, 0 sales |